Sultopride
| Sultopride | |
|---|---|
| Salts [] | |
|---|---|
| Sultopride hydrochloride | |
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 354.50 g/mol [1] |
| Predicted LogP | 1.6 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C17H26N2O4S |
| IUPAC name | N-[(1-ethylpyrrolidin-2-yl)methyl]-5-ethylsulfonyl-2-methoxybenzamide |
| SMILES | CCN1CCCC1CNC(=O)C2=C(C=CC(=C2)S(=O)(=O)CC)OC |
| InChI | InChI=1S/C17H26N2O4S/c1-4-19-10-6-7-13(19)12-18-17(20)15-11-14(24(21,22)5-2)8-9-16(15)23-3/h8-9,11,13H,4-7,10,12H2,1-3H3,(H,18,20) |
| InChIKey | UNRHXEPDKXPRTM-UHFFFAOYSA-N |
| CAS number | 53583-79-2 |
| UNII | AA0G3TW31W |
| PubChem CID | 5357 |
| Pharmacokinetics[] | |
|---|---|
| Elimination half-life | 3–5 hours |
| Routes of administration | Oral, intramuscular |
Sultopride (also known as Sultopridum, Sultoprida, N-((1-Ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-o-anisamide, Benzamide, N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-2-methoxy-, N-[(1-ethylpyrrolidin-2-yl)methyl]-5-ethylsulfonyl-2-methoxy-benzamide, N-((1-ethylpyrrolidin-2-yl)methyl)-5-ethylsulfonyl-2-methoxy-benzamide, (+-)-Sultopride, N05al02, N-(Ethyl-1-pyrrolidinyl-2-methyl)methoxy-2-ethylsulfonyl-5-benzamide or 258-641-9 and brand names including Barnetil, Barnotil, Topral) is a substance of the benzylamine class.
Chemistry
Salts []
Sultopride is typically found in the form of its hydrochloride salt.
Stereochemistry []
Sultopride is a racemic mixture of the enantiomers (optical activity ( + / - )).
Druglikeness
Lipinski's rule of five
Sultopride matches Lipinski's rule of five.Pharmacology
ATC Classification
MeSH Classification
- antipsychotic agents (M0021770)
- dopamine antagonists (M0027734)
- antidepressive agents, second-generation (M0028000)
Interactions []
Legal status []
- Brazil: Sultopride is a C1.[3]
- Other: Sultopride is a Rx-only.
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 5357, Sultopride. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/5357
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Sultopride. UNII: AA0G3TW31W. Global Substance Registration System. Accessed November 21, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/AA0G3TW31W
RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 2023-03-31. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 19:00:24 |
| drugspro | missing (no DrugsPRO reagent data) | 2026-11-20 19:00:20 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 19:00:19 |
| gsrs | ok | 2026-11-20 19:00:21 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0258623) | 2026-11-20 19:00:19 |
| kegg | ok | 2026-11-20 19:00:22 |
| pubchem | ok | 2026-11-20 19:00:18 |
| missing (no r/tripreports posts mention it) | 2026-11-20 19:00:20 | |
| sider | missing (not in SIDER) | 2026-11-20 19:00:19 |
| structure | ok | 2026-11-20 19:00:19 |
| wikipedia | ok | 2026-11-20 19:00:20 |